Cochrane Review Group
Common Mental Disorders
117 systematic reviews in Common Mental Disorders ask 2,206 questions. 17.5% have no studies to answer them, 28.8% rest on very low certainty evidence and 22.9% reach moderate or high certainty.
Reviews
117
Questions
2,206
current versions
No studies
17.5%
Moderate or high
22.9%
No studies 387 · 17.5%Ungraded 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Depressive symptomatology (lower = less depressive symptomatology): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 18 studies · 644 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Treatment non‐acceptability (higher = greater non‐acceptability): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 5 studies · 313 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Depression remission (presence or absence of MDD):end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 1 study · 82 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 6 studies · 195 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 2 studies · 115 participants | Very low |
Escitalopram vs placebo PTSD severity at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 23 participants | Very low |
Hydrocortisone vs placebo Quality of life at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 43 participants | Very low |
Escitalopram vs placebo Dropouts due to adverse events at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Escitalopram vs placebo PTSD rate at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | RR 0.59 [0.03, 13.08] | 1 study · 23 participants | Very low |
Escitalopram vs placebo Functional disability at 3 months ‐ not measured · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | NR | No studies |
Escitalopram vs placebo Quality of life at 3 months ‐ not measured · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | NR | No studies |
Hydrocortisone vs placebo PTSD severity at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 3 studies · 136 participants | Very low |
Reviews 117
Psychological therapies for post‐traumatic stress disorder and comorbid substance use disorder
CochraneSoF table
15 questions
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis
CochraneSoF table
20 questions
Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults
CochraneSoF table
9 questions
Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults
CochraneSoF table
25 questions
S‐adenosyl methionine (SAMe) for depression in adults
CochraneSoF table
20 questions
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults
CochraneSoF table
18 questions
Antidepressants and benzodiazepines for panic disorder in adults
CochraneSoF table
42 questions
Psychosocial interventions for self‐harm in adults
CochraneSoF table
46 questions
Psychological therapies for children and adolescents exposed to trauma
CochraneSoF table
4 questions
Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa
CochraneSoF table
15 questions
Cognitive behavioural therapy for anxiety disorders in children and adolescents
CochraneSoF table
9 questions
Debriefing interventions for the prevention of psychological trauma in women following childbirth
CochraneSoF table
7 questions
Pharmacotherapy for anxiety and comorbid alcohol use disorders
CochraneSoF table
7 questions
Augmentation of cognitive and behavioural therapies (CBT) with d‐cycloserine for anxiety and related disorders
CochraneSoF table
14 questions
Morita therapy for anxiety disorders in adults
CochraneSoF table
14 questions
Dance movement therapy for depression
CochraneSoF table
5 questions
Pharmacological interventions for self‐harm in adults
CochraneSoF table
5 questions
Interventions for self‐harm in children and adolescents
CochraneSoF table
11 questions
Antidepressant treatment for postnatal depression
CochraneSoF table
2 questions
Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD)
CochraneSoF table
2 questions
Paroxetine versus other anti‐depressive agents for depression
CochraneSoF table
133 questions
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults
CochraneSoF table
6 questions
Psychological, social and welfare interventions for psychological health and well‐being of torture survivors
CochraneSoF table
7 questions
Pharmacological interventions for somatoform disorders in adults
CochraneSoF table
35 questions
Azapirones versus placebo for panic disorder in adults
CochraneSoF table
5 questions